Y Intercept (Hong Kong) LTD Silence Therapeutics PLC Transaction History
Y Intercept (Hong Kong) LTD
- $1.58 Billion
- Q3 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 21,078 shares of SLN stock, worth $113,821. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,078
Previous 17,155
22.87%
Holding current value
$113,821
Previous $325,000
17.85%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
73Shares Held
28.1MCall Options Held
300Put Options Held
2K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$16.4 Million7.16% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$15.3 Million2.57% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.66MShares$14.4 Million3.3% of portfolio
-
Redmile Group, LLC San Francisco, CA1.9MShares$10.3 Million2.26% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.15MShares$6.2 Million1.12% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $194M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...